These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5998360)

  • 21. [Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
    Delaloye B; Magnenat P; Blanc B
    Nucl Med (Stuttg); 1967; ():97-111. PubMed ID: 5601765
    [No Abstract]   [Full Text] [Related]  

  • 22. Iron overload and psychiatric illness.
    Cutler P
    Can J Psychiatry; 1994 Feb; 39(1):8-11. PubMed ID: 8194001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Iron storage disease].
    Heilmeyer L
    Munch Med Wochenschr; 1967 Mar; 109(13):677-84. PubMed ID: 5631729
    [No Abstract]   [Full Text] [Related]  

  • 24. [Iron metabolism. Current aspects of iron overload].
    Williams R
    Recenti Prog Med; 1980 Feb; 68(2):97-127. PubMed ID: 6988908
    [No Abstract]   [Full Text] [Related]  

  • 25. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract]   [Full Text] [Related]  

  • 26. [Idiopathic hemochromatosis--diagnosis and therapy].
    Schmidt U; Preu E; Tuschy U; Senf L; Herre K
    Z Gesamte Inn Med; 1984 Apr; 39(8):152-60. PubMed ID: 6730591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Care of the Primary and Secondary Hemochromatosis Patients.
    Becker S
    J Infus Nurs; 2020; 43(2):65-69. PubMed ID: 32106193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemochromatosis].
    Phlippen R
    Munch Med Wochenschr; 1972 Feb; 114(5):147-9. PubMed ID: 5066916
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of primary hemochromatosis with deferoxamine.
    Young N; Henry W; Nienhuis AW
    JAMA; 1979 Mar; 241(11):1152-4. PubMed ID: 762769
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for hereditary hemochromatosis in prospective blood donors.
    Benn HP; Nielsen P; Fischer R; Schwarz D; Engelhardt R; Darda C; Dittmer R; Knödler B; Gabbe EE; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():314-6. PubMed ID: 9422115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.
    Nielsen P; Fischer R; Buggisch P; Janka-Schaub G
    Br J Haematol; 2003 Dec; 123(5):952-3. PubMed ID: 14632789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of primary hemochromatosis treated with desferol].
    Lawecki J; Rogala H
    Wiad Lek; 1966 Oct; 19(19):1543-7. PubMed ID: 5977345
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiology and physiopathology of iron metabolism].
    Linkesch W
    Wien Med Wochenschr; 1984 Feb; 134(3-4):59-63. PubMed ID: 6324499
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of phenylhydrazine-induced haemolysis on the urinary excretion of iron after desferrioxamine.
    Cumming RL; Goldberg A; Morrow J; Smith JA
    Lancet; 1967 Jan; 1(7481):71-4. PubMed ID: 4163055
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
    Strohmeyer G
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2295-9. PubMed ID: 4448138
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
    Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
    Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
    Maspes V; Tamigaki M; Gomes ZJ; Jamra M
    Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
    [No Abstract]   [Full Text] [Related]  

  • 39. [A case of hemochromatosis treated with desferrioxamine].
    Dowzenko A; Marecik-Piasecka G; Palynyczko Z
    Pol Tyg Lek; 1967 May; 22(18):678-9. PubMed ID: 6078337
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term intraperitoneal deferoxamine for hemochromatosis.
    Swartz RD; Legault DJ
    Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.